News Releases

Boston Scientific To Participate In BMO Capital Markets Prescriptions For Success Healthcare Conference

MARLBOROUGH, Mass., Dec. 4, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the BMO Capital Markets Prescriptions for Success Healthcare Conference on December 14, 2017 in New York.

Susie Lisa, vice president, investor relations, and Lindsay Fish, senior manager, investor relations will participate in a 30-minute question-and-answer session with the host analyst beginning at approximately 8:00 a.m. EST.

A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour after the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:

Investors:

Kate Haranis

Susie Lisa, CFA

508-683-6585 (office)

508-683-5565 (office)

Media Relations

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

kate.haranis@bsci.com

investor_relations@bsci.com

 

SOURCE Boston Scientific Corporation